Snowball logo
logo
ATHX

Athersys Inc

ATHXQ • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-0.17
Beta
50.159
About the company
Ticker
ATHXQ
ISIN
Country
United States of America
Sector (GICS)
Healthcare
Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.

Frequently asked questions

What sector does Athersys Inc (ATHXQ) operate in?

Athersys Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Athersys Inc (ATHXQ) current stock price?

As of the latest data, Athersys Inc stock price is $0.00, with a previous close of $0.00.

What is Athersys Inc (ATHXQ) current market capitalization?

Athersys Inc market cap is approximately 6.17 thousand.

What is Athersys Inc (ATHXQ) Earnings Per Share (EPS)?

The trailing EPS is -$0.17.

Does Athersys Inc (ATHXQ) pay dividends?

No. Athersys Inc does not pay a dividend.

What is Athersys Inc (ATHXQ) beta (volatility) score?

Athersys Inc has a beta of 50.159, indicating very high volatility compared to the market.